Company intelligence
AiM Medical Robotics
Helping surgeons hit their targets the first time, every time with MRI-guided robotic neurosurgery.
About AiM Medical Robotics
AiM Medical Robotics brings precision, automation, and real-time imaging to the most complex environment in medicine: neurosurgery. Our portable robotic platform leverages MRI compatibility alongside other forms of image guidance to deliver unmatched precision, cutting procedure times by up to 50%, helping surgeons hit their targets the first time, and improving outcomes for patients with Parkinson's disease, epilepsy, and brain cancer. For decades, stereotactic neurosurgery has been built on a pre-operative plan. But once the case begins, the brain moves. Fluid loss, swelling, and positioning shift the anatomy by millimeters, enough to miss a target the size of a grain of rice. The visible cost is the roughly one in three DBS leads that need revision, more than half of those due to misplacement. The larger, quieter cost is the patients living with suboptimal outcomes and reduced quality of life from misplaced leads that never get revised, because some benefit is better than another operation. We're building a new category: real-time MRI-guided robotic neurosurgery. Our robot operates inside the MRI scanner, allowing surgeons to see live anatomy, replan during the case, and deliver sub-millimeter accuracy, confirmed before the patient leaves the OR. The platform is portable, fits existing ORs and MRI suites without modification, and integrates with Synaptive Medical's Modus Nav for a unified workflow. Where we are: First-in-human clinical study underway at Brigham and Women's Hospital, in the AMIGO suite, with Harvard's Surgical Navigation & Robotics Lab. Dr. Yulun Wang, founder of Computer Motion and InTouch Health, joined our board in March 2026 to guide AiM from first-in-human to commercial launch. Headquartered at PracticePoint in Worcester, MA, built on 15+ years of NIH-funded research at Worcester Polytechnic Institute. For surgeons, hospitals, investors, and partners ready to move neurosurgery from static plans to live, image-guided precision. Let's talk.
Verified activity
Signals from AiM Medical Robotics
4 published signals
Presence & Recognition
AiM Medical Robotics was featured in a weekly newsletter feature by the LSI community.
Reported by AiM Medical Robotics
Research & Knowledge
AiM Medical Robotics tracked 5,179 agents using a copilot that suggested replies in real time and issues resolved per hour rose 14 percent.
Reported by Dave Saunders - CPO
Capital & Finance
AiM Medical Robotics was awarded a $2M Phase II NIH SBIR grant from the National Cancer Institute to advance MRI-guided robotic treatment of brain cancer.
Reported by AiM Medical Robotics
Capital & Finance
AiM Medical Robotics received a $2M Phase II SBIR grant from the National Cancer Institute to advance its MRI-guided robotic platform for brain cancer treatment.
Reported by Gregory Fischer